Related Experiment Videos
The management of exfoliative glaucoma
1New York Eye and Ear Infirmary, New York, New York 10003, USA. ritchmd@earthlink.net
Progress in Brain Research
|October 22, 2008
Summary
Exfoliation syndrome (XFS) is a common cause of glaucoma linked to extracellular matrix and elastic tissue abnormalities. Genetic variations in the LOXL1 gene are strongly associated with XFS, offering potential therapeutic targets.
Area of Science:
- Ophthalmology
- Genetics
- Biochemistry
Background:
- Exfoliation syndrome (XFS) is an age-related extracellular matrix disorder causing fibrillar material accumulation in ocular tissues.
- XFS is the leading identifiable cause of open-angle glaucoma worldwide and is linked to cataracts and retinal vein occlusion.
- Systemic associations include vascular disorders, hearing loss, and Alzheimer's disease, suggesting a broader impact on elastic tissues.
Purpose of the Study:
- To investigate the genetic basis of exfoliation syndrome (XFS) and its association with glaucoma.
- To identify specific genes and their variations contributing to the development of XFS and exfoliation glaucoma (XFG).
- To explore the role of LOXL1 in the pathogenesis of XFS and its ocular manifestations.
Main Methods:
- Genome-wide association study (GWAS) to identify genetic variants associated with XFS and XFG.
- Analysis of single nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1 (LOXL1) gene.
- Biochemical analysis of LOXL1 protein in ocular tissues affected by XFS.
Main Results:
- Two common SNPs in the coding region of the LOXL1 gene were significantly associated with XFS and XFG.
- LOXL1 protein was identified as a major component of exfoliation deposits.
- LOXL1 appears to play a crucial role in the accumulation of fibrillar material and elastotic changes in XFS.
Conclusions:
- Genetic variations in LOXL1 are strongly linked to the development of exfoliation syndrome and associated glaucoma.
- LOXL1's role in elastic fiber formation and remodeling is critical in XFS pathogenesis.
- Targeting LOXL1 may offer novel therapeutic strategies for XFS and related ocular conditions.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...